Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.
about
α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissuesCancer biomarker discovery: the entropic hallmark.Expression and characterization of α-methylacyl CoA racemase from Anisakis simplex larvae.A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.Primary signet ring cell carcinoma of the prostate.High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.Gene panel model predictive of outcome in patients with prostate cancer.Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions.Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma.Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in situ vs invasive urothelial cancer in the prostate.The diagnostic utility of the minimal carcinoma triple stain in breast carcinomas.Prostate cancer: diagnostic criteria and role of immunohistochemistry.Benign mimics of prostatic adenocarcinoma.
P2860
Q24605772-21577135-FCB9-439F-986C-431FB68C8EC5Q30496149-E1F7E335-C9C8-4A70-B2E3-5E650F9491ACQ34308616-822B2CFA-795C-44BA-A66D-2DA9D6B7F64BQ35018146-CA73FD09-76F5-4155-BE36-C078A2E7F1ABQ37814775-37BFB77A-738A-4F53-B059-621F64287634Q38737037-6A16417E-46AC-4175-8B93-0482D851AC50Q39403730-0BF58F5A-0DFF-4E13-BFA6-132D5B41513FQ41847488-251CBC8E-43AA-4A57-BDD3-3643DEFEAB52Q42323151-115E1925-CE72-4F66-B740-EB910ECC3271Q42438388-BAAB1956-07D6-4DDD-B32E-63158DB589C0Q42511446-802E2DE7-4198-4C58-8D1A-69D7AD4A42C6Q45774429-754E529F-133E-4258-B115-5DF01D8AC242Q49347844-57ADDF89-97C1-4050-A9A6-307E5979B68EQ49347853-84A6BAEC-FE5A-4658-8440-BDE30B46F73A
P2860
Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@en
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@nl
type
label
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@en
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@nl
prefLabel
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@en
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@nl
P2093
P2860
P356
P1476
Usefulness of cytokeratin 5/6 ...... roblematic prostate specimens.
@en
P2093
Asli Yilmaz
Joanna Bartczak-McKay
Kiril Trpkov
P2860
P304
211-20; quiz 307
P356
10.1309/AJCPGFJP83IXZEUR
P407
P577
2009-08-01T00:00:00Z